+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cyclophosphamide"

Ovarian Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Ovarian Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Generic Oncology Drugs Global Market Report 2024 - Product Thumbnail Image

Generic Oncology Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Gestational Trophoblastic Disease Global Market Report 2024 - Product Thumbnail Image

Gestational Trophoblastic Disease Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Germ Cell Tumor Global Market Report 2024 - Product Thumbnail Image

Germ Cell Tumor Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
Lupus Nephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Still's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Still's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

Cyclophosphamide is a drug used to treat immune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, and vasculitis. It is a type of alkylating agent, which works by inhibiting the growth of certain cells in the body. It is usually administered intravenously or orally, and is often used in combination with other drugs. Cyclophosphamide is also used to treat certain types of cancer, such as lymphoma and leukemia. Cyclophosphamide is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other drugs. It is generally well tolerated, with few side effects. However, it can cause serious side effects, such as bone marrow suppression, and should be used with caution. Some of the companies in the Cyclophosphamide market include Pfizer, Novartis, Merck, and Bristol-Myers Squibb. Show Less Read more